Back to news

MyTwin x Skinive: assessing skin condition risk from a simple photo

Published on October 16, 2025·by Rubens Valcy·1 min read
MyTwin x Skinive: assessing skin condition risk from a simple photo

New feature for MyTwin: thanks to a partnership with Skinive, the human body digital twin can now analyze a skin photo and inform users about the risk level of a skin condition.

The Partnership with Skinive

Skinive is a company specializing in AI-powered dermatological analysis. Their algorithm has been trained on millions of medical images and can assess the risk level associated with various skin lesions.

How Does It Work?

The process is strikingly simple:

  1. The user takes a photo of a mole, spot or blemish that concerns them.
  2. The AI analyzes the image in seconds.
  3. MyTwin provides a risk level assessment for the lesion. This result must then be reviewed and verified by a healthcare professional.

This is not a diagnosis, but an informational tool that helps guide users and encourages them to consult a specialist if needed.

A Public Health Issue

Skin cancer is one of the most common cancers worldwide, but also one of the most curable when detected at an early stage. The problem: many people don't visit a dermatologist regularly, due to lack of time, access or simply oversight.

By integrating skin risk assessment into MyTwin, prevention becomes a daily reflex. Worried about a mole? A photo is all it takes to get an initial assessment and know whether it's worth consulting a dermatologist.

MyTwin, a Comprehensive Prevention Platform

With voice analysis (Virtuosis AI), vital sign measurement by video (rPPG) and now dermatological screening (Skinive), MyTwin establishes itself as a comprehensive health prevention platform, covering an ever-wider spectrum of conditions, all from a simple smartphone.